Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Operating Grant: ECRs in Human Development, Child and Youth Health

University of Calgary

$149,892.00

DOnor milk to REpair the MIcrobiome in full-term infants born via Cesarean Section (DO-RE-MI C-Section)

EF 2024-25

Résumé
The first 1000 days of a baby's life are critical for their growth and development, which is highly influenced by bacteria, viruses and fungi in their gut (microbiome). In Canada, over 30% of babies are born via caesarean section (c-section), which can affect their gut microbiome development. Exclusive breastfeeding supports healthy gut microbiome development; however, many babies, especially those born via c-section, require supplementation of breastfeeding, usually with formula. Formula supplementation can negatively affect the gut microbiome. Donor human milk (DHM) offers an alternative to formula that may support gut health because babies remain exclusively human milk fed. Further, using DHM instead of formula may impact breastfeeding outcomes. However, little is known about the effects of DHM on the gut microbiome of full-term babies and if families continue to successfully breastfeed after DHM supplementation early in life. Our pilot study will compare how DHM versus formula supplementation affects the gut microbiome, health outcomes, and breastfeeding outcomes of 187 full-term mother-baby pairs born via c-section. When supplementation is required, babies will receive either DHM or formula for the first 7 days of life, with stool samples collected at 1 week, 3, 6, and 12 months for microbiome analysis. We will measure the different types of microbes growing in the guts of babies fed DHM compared to formula. We will also explore if there are differences in growth, sleep, and overall physical health and development up to 3 years and if DHM supplementation impacts breastfeeding outcomes in the first year of life. This research will provide crucial insights into the impact of DHM on the developing gut microbiome and how DHM compared to formula supplementation influences long-term health. It will guide future large-scale studies on early nutrition and child development aimed at enabling families with informed feeding choices for better infant and maternal outcomes.
Programme
Operating Grant: ECRs in Human Development, Child and Youth Health
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
511170
Name
Brockway Meredith
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Human Development, Child and Youth Health
Theme2
Clinical
Prcname2
Early Career Researchers in Human Development, Child and Youth Health (2025)
Projecttitle
DOnor milk to REpair the MIcrobiome in full-term infants born via Cesarean Section (DO-RE-MI C-Section)
Programtype2
Operating Grants
Orgnameinp2
University of Calgary
Cihramount2
$149,892
Cihrequipment2
$0
Programname2
Operating Grant: ECRs in Human Development, Child and Youth Health
Keyworddelim
Breastfeeding; Breastfeeding Duration; Breastfeeding Exclusivity; Donor Human Milk; Full-Term Infant; Gut Microbiome; Infant Formula; Randomized Controlled Trial
Abstract
The first 1000 days of a baby's life are critical for their growth and development, which is highly influenced by bacteria, viruses and fungi in their gut (microbiome). In Canada, over 30% of babies are born via caesarean section (c-section), which can affect their gut microbiome development. Exclusive breastfeeding supports healthy gut microbiome development; however, many babies, especially those born via c-section, require supplementation of breastfeeding, usually with formula. Formula supplementation can negatively affect the gut microbiome. Donor human milk (DHM) offers an alternative to formula that may support gut health because babies remain exclusively human milk fed. Further, using DHM instead of formula may impact breastfeeding outcomes. However, little is known about the effects of DHM on the gut microbiome of full-term babies and if families continue to successfully breastfeed after DHM supplementation early in life. Our pilot study will compare how DHM versus formula supplementation affects the gut microbiome, health outcomes, and breastfeeding outcomes of 187 full-term mother-baby pairs born via c-section. When supplementation is required, babies will receive either DHM or formula for the first 7 days of life, with stool samples collected at 1 week, 3, 6, and 12 months for microbiome analysis. We will measure the different types of microbes growing in the guts of babies fed DHM compared to formula. We will also explore if there are differences in growth, sleep, and overall physical health and development up to 3 years and if DHM supplementation impacts breastfeeding outcomes in the first year of life. This research will provide crucial insights into the impact of DHM on the developing gut microbiome and how DHM compared to formula supplementation influences long-term health. It will guide future large-scale studies on early nutrition and child development aimed at enabling families with informed feeding choices for better infant and maternal outcomes.
Competitiondate
202409
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Brockway, Meredith
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $149,892~ $0~